Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

12 Nov 2019

Lassa Fever – an emerging disease we should look out for
Why we need a Lassa Vaccine and why you should care about Lassa

Read more

Read article

31 Oct 2019

Global consortium working with DRC Government to introduce second Ebola vaccine
Trial aims to help tackle outbreak and strengthen future Ebola epidemic preparedness.

Read more

29 Oct 2019

Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine
Coalition for Epidemic Preparedness Innovations (CEPI) partnership will support Themis’ development and manufacturing of vaccine candidate

Read more

15 Oct 2019

Faster, more agile vaccine tech needed to fight tomorrow’s epidemics

Read more

15 Oct 2019

CEPI launches new call for innovative platform technologies to rapidly respond to Disease X
New call for proposals invites applications for platform technologies to quickly develop vaccines and immunoprophylactics against Disease X

Read more

18 Sep 2019

A World at Risk: Global Preparedness Monitoring Board launches first annual report
The report, based off of evidence from seven review papers that explore the challenge of outbreak preparedness, outlines the growing threat and potential devastation of infectious disease epidemics, alongside the urgent need for investment.

Read more

21 Aug 2019

CEPI and Africa CDC to host panel event at TICAD 7
Event will explore how epidemic preparedness and response in Africa can be strengthened

Read more

12 Aug 2019

CEPI awards up to US$43.6 million to Public Health Vaccines, LLC. for development of a single-dose Nipah virus vaccine candidate
Public Health Vaccine, LLC. will partner with Crozet BioPharma to develop the Nipah vaccine candidate. Up to $9 million of this funding will go to Ology Bioservices, Inc., to support manufacturing and stockpiling of the vaccine.

Read more

Read article

12 Aug 2019

Strengthening epidemic preparedness and response in Africa
Find out about Africa CDC's and CEPI's official side event at TICAD 7 on August 28, 2019

Read more

25 Jul 2019

CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine

Read more

17 Jul 2019

CEPI awards funding agreement worth up to US$9.5 million to Colorado State University to develop a human vaccine against Rift Valley fever

Read more

©2019 CEPI. All rights reserved

This website uses cookies to improve functionality and performance. If you continue browsing the site, you consent to the use of cookies on this website. For details, see our Cookie Notice.